Sumatriptan and migraine.
Akpunonu
B E
BE
Mutgi
A B
AB
D003362:Cost-Benefit Analysis; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000191:economics; D018170:Sumatriptan / Q000191:economics* / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000191:economics* / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D018170:Sumatriptan